{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:59:27Z","timestamp":1791496767008,"version":"4.3.4"},"reference-count":101,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00157","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T03:06:19Z","timestamp":1461553579000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy"],"prefix":"10.3389","volume":"7","author":[{"given":"Dorin-Bogdan","family":"Borza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,25]]},"reference":[{"issue":"6","key":"B1","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1172\/JCI72270","article-title":"Membranous nephropathy: from models to man","volume":"124","author":"Beck","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"B2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0270-9295(03)00058-5","article-title":"Hyperlipidemia and thrombotic complications in patients with membranous nephropathy","volume":"23","author":"Nickolas","year":"2003","journal-title":"Semin Nephrol"},{"issue":"1","key":"B3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.ajkd.2010.01.008","article-title":"The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey","volume":"56","author":"Glassock","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10157-005-0357-8","article-title":"Mechanisms of immune-deposit formation and the mediation of immune renal injury","volume":"9","author":"Nangaku","year":"2005","journal-title":"Clin Exp Nephrol"},{"issue":"22","key":"B5","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"B6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V6135","article-title":"The Heymann nephritis antigenic complex: megalin (gp330) and RAP","volume":"6","author":"Farquhar","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"26","key":"B7","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"issue":"9441","key":"B8","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"B10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"B12","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"issue":"5844","key":"B14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"2","key":"B15","first-page":"415","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"B16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"3","key":"B17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol"},{"issue":"1","key":"B18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.ajkd.2014.06.035","article-title":"Complement in kidney disease: core curriculum 2015","volume":"65","author":"Thurman","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"B19","doi-asserted-by":"publisher","first-page":"F660","DOI":"10.1152\/ajprenal.00437.2004","article-title":"Experimental membranous nephropathy redux","volume":"289","author":"Cybulsky","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"B20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1681\/ASN.2005010096","article-title":"Contrasting roles of complement activation and its regulation in membranous nephropathy","volume":"16","author":"Cunningham","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"B21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","article-title":"IgG subclasses and complement pathway in segmental and global membranous nephropathy","volume":"25","author":"Segawa","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"B22","doi-asserted-by":"publisher","first-page":"c147","DOI":"10.1159\/000079174","article-title":"Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy","volume":"97","author":"Endo","year":"2004","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"B23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000183255","article-title":"Demonstration of C3d deposits in membranous nephropathy","volume":"37","author":"Doi","year":"1984","journal-title":"Nephron"},{"issue":"1","key":"B24","first-page":"179","article-title":"Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis","volume":"142","author":"Schulze","year":"1993","journal-title":"Am J Pathol"},{"issue":"4","key":"B25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ki.1992.143","article-title":"Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy","volume":"41","author":"Brenchley","year":"1992","journal-title":"Kidney Int"},{"issue":"6","key":"B26","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/ki.1995.496","article-title":"Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy","volume":"48","author":"Kon","year":"1995","journal-title":"Kidney Int"},{"issue":"5","key":"B27","first-page":"397","article-title":"The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy","volume":"8","author":"Coupes","year":"1993","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"B28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI109987","article-title":"A new role for complement in experimental membranous nephropathy in rats","volume":"66","author":"Salant","year":"1980","journal-title":"J Clin Invest"},{"issue":"1","key":"B29","first-page":"185","article-title":"Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats","volume":"135","author":"Baker","year":"1989","journal-title":"Am J Pathol"},{"issue":"4","key":"B30","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1172\/JCI112408","article-title":"Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy","volume":"77","author":"Cybulsky","year":"1986","journal-title":"J Clin Invest"},{"issue":"5","key":"B31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2004121098","article-title":"Cellular response to injury in membranous nephropathy","volume":"16","author":"Nangaku","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"B32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ndt\/13.suppl_1.10","article-title":"Pathogenesis of glomerular damage in glomerulonephritis","volume":"13","author":"Couser","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"B33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/ASN.2004121080","article-title":"Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization","volume":"16","author":"Ronco","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"B34","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ki.2014.381","article-title":"Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies","volume":"87","author":"Vivarelli","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"B35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0090-1229(84)90059-X","article-title":"Factors influencing susceptibility of LEW rats to Heymann nephritis","volume":"30","author":"Noble","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"B36","first-page":"57","article-title":"Distribution of IgG subclasses in membranous nephropathy","volume":"58","author":"Doi","year":"1984","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"B37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/ajcp\/83.4.415","article-title":"Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens","volume":"83","author":"Jennette","year":"1985","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"B38","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"B39","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"B40","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"B41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fimmu.2013.00235","article-title":"Temporal model of human IgE and IgG antibody function","volume":"4","author":"Collins","year":"2013","journal-title":"Front Immunol"},{"issue":"6","key":"B43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","article-title":"Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review","volume":"57","author":"Maverakis","year":"2015","journal-title":"J Autoimmun"},{"issue":"4","key":"B46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/ndt\/14.4.881","article-title":"Glomerular deposition of mannose-binding lectin in human glomerulonephritis","volume":"14","author":"Lhotta","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B47","first-page":"62A","article-title":"Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway (abstract)","volume":"22","author":"Ma","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"B48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2249.2004.02627.x","article-title":"The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation","volume":"138","author":"Harboe","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"B49","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1074\/jbc.M508928200","article-title":"The role of properdin in the assembly of the alternative pathway C3 convertases of complement","volume":"281","author":"Hourcade","year":"2006","journal-title":"J Biol Chem"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.4049\/jimmunol.179.4.2600","article-title":"Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly","volume":"179","author":"Spitzer","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"B51","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1074\/jbc.M110.167825","article-title":"Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease","volume":"286","author":"Zaferani","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"B52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molimm.2013.06.002","article-title":"Properdin in complement activation and tissue injury","volume":"56","author":"Lesher","year":"2013","journal-title":"Mol Immunol"},{"issue":"4","key":"B53","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/ndt\/gfh008","article-title":"Membranous nephropathy in a patient with hereditary complete complement C4 deficiency","volume":"19","author":"Lhotta","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"B54","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1681\/ASN.2013050498","article-title":"Neonatal fc receptor promotes immune complex-mediated glomerular disease","volume":"25","author":"Olaru","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"B55","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.4049\/jimmunol.1103368","article-title":"Murine membranous nephropathy: immunization with alpha3(IV) collagen fragment induces subepithelial immune complexes and FcgammaR-independent nephrotic syndrome","volume":"188","author":"Zhang","year":"2012","journal-title":"J Immunol"},{"key":"B56","first-page":"62A","article-title":"Alternative complement pathway is essential for glomerular C3 deposition and progressive proteinuria in murine membranous nephropathy [Abstract FR-OR140]","volume":"23","author":"Luo","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"B57","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1084\/jem.188.7.1353","article-title":"Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis","volume":"188","author":"Schiller","year":"1998","journal-title":"J Exp Med"},{"issue":"3","key":"B58","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4049\/jimmunol.147.3.838","article-title":"Effect of nephritogenic antibody on complement regulation in cultured rat glomerular epithelial cells","volume":"147","author":"Quigg","year":"1991","journal-title":"J Immunol"},{"issue":"7","key":"B59","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.154.7.3437","article-title":"Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis","volume":"154","author":"Quigg","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1523-1755.2001.00476.x","article-title":"No complement receptor 1 stumps on podocytes in human glomerulopathies","volume":"59","author":"Moll","year":"2001","journal-title":"Kidney Int"},{"issue":"8","key":"B61","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol"},{"issue":"4","key":"B62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodriguez de Cordoba","year":"2004","journal-title":"Mol Immunol"},{"issue":"1","key":"B63","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.155.1.348","article-title":"Identification of complement regulatory domains in human factor H","volume":"155","author":"Gordon","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"B64","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4049\/jimmunol.181.4.2610","article-title":"A new map of glycosaminoglycan and C3b binding sites on factor H","volume":"181","author":"Schmidt","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"B65","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000356513","article-title":"The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?","volume":"6","author":"Langford-Smith","year":"2014","journal-title":"J Innate Immun"},{"issue":"1","key":"B66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"1\u20132","key":"B67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0162-3109(00)80160-5","article-title":"Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement","volume":"49","author":"Pangburn","year":"2000","journal-title":"Immunopharmacology"},{"issue":"10","key":"B68","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","article-title":"Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid\/polyanion binding site on factor H","volume":"87","author":"Meri","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"B69","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1073\/pnas.1017087108","article-title":"Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement","volume":"108","author":"Kajander","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"B70","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1016\/j.molimm.2006.12.001","article-title":"The C-terminus of complement factor H is essential for host cell protection","volume":"44","author":"Jozsi","year":"2007","journal-title":"Mol Immunol"},{"issue":"1","key":"B71","first-page":"251","article-title":"Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology","volume":"19","author":"Jozsi","year":"2004","journal-title":"Histol Histopathol"},{"issue":"9","key":"B72","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.4049\/jimmunol.177.9.6308","article-title":"Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces","volume":"177","author":"Ferreira","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"B73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1681\/ASN.2005080868","article-title":"Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions","volume":"17","author":"Jozsi","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"B74","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"B75","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"B76","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"issue":"28","key":"B77","doi-asserted-by":"publisher","first-page":"17832","DOI":"10.1074\/jbc.273.28.17832","article-title":"Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies","volume":"273","author":"Raats","year":"1998","journal-title":"J Biol Chem"},{"issue":"5","key":"B78","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol"},{"issue":"9","key":"B79","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.4049\/jimmunol.0903596","article-title":"Heparan sulfate, including that in Bruch\u2019s membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration","volume":"185","author":"Kelly","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"B80","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.1993.67","article-title":"Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases","volume":"43","author":"van den Born","year":"1993","journal-title":"Kidney Int"},{"issue":"8","key":"B81","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.V1081689","article-title":"Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis","volume":"10","author":"Raats","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"B82","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1097\/01.ASN.0000142426.55612.6D","article-title":"A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis","volume":"15","author":"Levidiotis","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"B83","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.ki.5002337","article-title":"Heparanase in glomerular diseases","volume":"72","author":"van den Hoven","year":"2007","journal-title":"Kidney Int"},{"issue":"7","key":"B84","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/10518","article-title":"Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis","volume":"5","author":"Vlodavsky","year":"1999","journal-title":"Nat Med"},{"issue":"1","key":"B85","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.ASN.0000103229.25389.40","article-title":"Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis","volume":"15","author":"Levidiotis","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"B86","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1093\/ndt\/gfr732","article-title":"Urinary heparanase activity in patients with Type 1 and Type 2 diabetes","volume":"27","author":"Rops","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"B87","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2215\/CJN.01450214","article-title":"Glomerular disease: looking beyond pathology","volume":"9","author":"Wiggins","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"B88","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2215\/CJN.07570712","article-title":"Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials","volume":"8","author":"Chen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"B89","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"B90","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2215\/CJN.05231008","article-title":"Rituximab therapy for membranous nephropathy: a systematic review","volume":"4","author":"Bomback","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"B91","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.2215\/CJN.05080610","article-title":"Rituximab therapy in idiopathic membranous nephropathy: a 2-year study","volume":"5","author":"Fervenza","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"B92","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2215\/CJN.04321007","article-title":"Idiopathic membranous nephropathy: diagnosis and treatment","volume":"3","author":"Fervenza","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"B93","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1681\/ASN.2012010058","article-title":"Treatment of idiopathic membranous nephropathy","volume":"23","author":"Waldman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B94","first-page":"668A","article-title":"Eculizumab (C5a complement inhibitor) in the treatment of idiopathic membranous nephropathy [abstract]","volume":"13","author":"Appel","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"B95","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.0601094103","article-title":"Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice","volume":"103","author":"Pickering","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molimm.2004.07.043","article-title":"A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice","volume":"42","author":"Thurman","year":"2005","journal-title":"Mol Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2015.08.001","article-title":"Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice","author":"Grossman","year":"2015","journal-title":"Immunobiology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4614-4118-2_9","article-title":"CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation","volume":"735","author":"Holers","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"B99","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.4049\/jimmunol.181.11.8068","article-title":"A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia\/reperfusion injury","volume":"181","author":"Huang","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"B100","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/art.30222","article-title":"The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL\/lpr mice","volume":"63","author":"Sekine","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"B101","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1681\/ASN.2014121195","article-title":"Efficacy of targeted complement inhibition in experimental C3 glomerulopathy","volume":"27","author":"Ruseva","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:21:56Z","timestamp":1692300116000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00157\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,25]]},"references-count":101,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00157","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,25]]}}}